Is the Level of Skin Autofluorescence (SAF) Related to Complications in Pregnant Patients with Diabetes Mellitus?

Is the Level of Skin Autofluorescence (SAF) Related to Complications in Pregnant Patients with Diabetes Mellitus? - Skin Autofluorescence in Pregnant Patients with Diabetes Mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34626

Enrollment

300

Registered

2010-02-24

Start date

2010-03-09

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Pregnant patients with diabetes (GDM or pre-existent diabetes mellitus) or patients with one abnormal value at OGTT -Written informed consent -Knowledge of Dutch

Exclusion criteria

Exclusion criteria: -renal failure (GFR

Design outcomes

Primary

Measure	Time frame
SAF level	—

Secondary

Measure	Time frame
complications necessity of insulin type 2 diabetes after diagnosis glucose values at OGTT	—

Countries

Netherlands

Outcome results